Richard Katz Net Worth & Insider Trades
Richard Katz - Vice President and CFO, Argos Therapeutics Inc
What is Richard Katz's Net Worth?
The current estimated net worth of Argos Therapeutics Inc's Vice President and CFO, Richard Katz, is estimated to be about $153.13K . Richard Katz owns about 193,959 units of Argos Therapeutics Inc common stock. In the last 2 years at Argos Therapeutics Inc, Richard Katz has sold an estimated value of $33.74K worth.
What is Richard Katz's Past Insider Trading?
Richard Katz's largest sale order was 104,435 units , worth over $17.2K on January 12, 2018. In total, Richard Katz has made about 7 transactions over 2 years of their time at Argos Therapeutics Inc. Richard Katz usually trades in January, with the busiest year in 2018.
Richard Katz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Richard Katz's' Mailing Address?
- Mailing address is 4505 Emperor Boulevard Suite 300 Durham NC 27703 NC
Argos Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Jeffrey D. Abbey | 2016 | $450,000 | $356,500 | $1,029,892 | $26,477 | $1,862,869 |
| Jeffrey D. Abbey | 2015 | $450,000 | $202,500 | $714,502 | $14,861 | $1,381,863 |
| Charles A Nicolette, Ph.D. | 2016 | $325,000 | $121,875 | $720,925 | $18,669 | $1,186,469 |
| Charles A Nicolette, Ph.D. | 2015 | $325,000 | $108,875 | $446,564 | $17,217 | $897,656 |
| Lee F. Allen, M.D., Ph.D. | 2016 | $407,292 | $389,375 | $1,016,592 | $70,120 | $1,883,379 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm
What are Argos Therapeutics Inc's Past Insider Trades?
Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer, Pharmstandard Co Stock Joint, and Sa International Pharmstandard .
ARGOS THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||